This takes some serious stones:

Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years.
[]
This year’s increases mean the average annual cost for a brand-name prescription drug that is taken daily would be more than $2,000 — $200 higher than last year, Professor Schondelmeyer said.

But there’s a great reason for this I see:

[D]rug companies say they are having to raise prices to maintain the profits necessary to invest in research and development of new drugs as the patents on many of their most popular drugs are set to expire over the next few years.

Right. Ready to expire. Like Enbrel, the biologic drug used to treat arthritis? Jay Inslee tells me that drugmakers spent $1.2 billion to develop that one. Which turns out not to be exactly true. Looks like you paid for more than the drug makers did:

[A]n analysis by Knowledge Ecology International shows that it is doubtful that Amgen spend more than $400 million on clinical development of the drug before approval, and that more than half of the early Phase I and II clinical trials on this drug were funded by the government through NIH or by universities. Amgen invested money, but invested most of its money late, when the risks were low. And, on top of this, some of the Amgen outlays on clinical trials qualified for the orphan drug tax credit, which means that U.S. taxpayers pick up half the costs of those trials.

Maybe granting drug companies an “indefinite monopoly” (in the words of Henry Waxman) isn’t the greatest idea? Even if you think someone will wave a magic wand and make biologic drugs available to you, the $50,000 to $300,000 annual pricetag is going to put it out of the reach of countries already struggling to provide health care.


Ask Sherrod Brown to save us from PhRMA and the Eshoo/Hagan/ lobbyist-written biologics legislation HERE
.

Fighting PhRMA Owned by PhRMA
Script: “Thank Senator X for standing up to PhRMA and making biologic ‘drugs of the future’ available as generics on behalf of those with childhood diabetes, cancer and AIDS. Please keep fighting and bring this bill to the floor as Senate amendment.” Script: “Will Senator X continue to do PhRMA’s bidding just like 42 Members of the House did and grant endless monopolies to drug companies on drugs developed with taxpayer dollars, or will they support Senator Brown’s amendment to make lifesaving biologic drugs available as affordable generics in my lifetime?”
B000944 Sherrod Brown
(202) 224-2315
Web Form: brown.senate.gov/

Write on Sherrod Brown’s Facebook Wall

Twitter Sherrod Brown

Kay Hagan
(202) 224-6342
Web Form: hagan.senate.gov/

Write on Kay Hagan’s Facebook Wall

Twitter Kay Hagan

S000148 Chuck Schumer
(202) 224-6542
Web Form: schumer.senate.gov/

Write on Chuck Schumer’s Facebook Wall

Twitter Chuck Schumer

H000338 Orrin Hatch
(202) 224-5251
Web Form: hatch.senate.gov/

Write on Orrin Hatch’s Facebook Wall

Twitter Orrin Hatch

S000770 Debbie Stabenow
(202) 224-4822
Web Form: stabenow.senate.gov/

Write on Debbie Stabenow’s Facebook Wall

E000285 Mike Enzi
(202) 224-3424
Web Form: enzi.senate.gov/

Write on Mike Enzi’s Facebook Wall

C001035 Susan Collins
(202) 224-2523
Web Form: collins.senate.gov/

Write on Susan Collins’ Facebook Wall

Twitter Susan Collins

V000127 David Vitter
(202) 224-4623
Web Form: vitter.senate.gov/

Write on David Vitter’s Facebook Wall

Twitter David Vitter